Kateir Contreras

Kateir Contreras

Auto-generated profile, based on publicly available information

Kateir Contreras

Departamento de Medicina Interna, Unidad de Nefrología Hospital Universitario San Ignacio Bogotá Colombia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2020 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
DFDaniel G. Fernández-Ávila
Daniel G. Fernández-Ávila
JRJulián Rondón-Carvajal
Julián Rondón-Carvajal
CVCatalina Villota-Eraso
Catalina Villota-Eraso
JGJuan Martín Gutiérrez-Dávila
Juan Martín Gutiérrez-Dávila
KCKateir Mariel Contreras-Villamizar
Kateir Mariel Contreras-Villamizar

7 April 2022 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
CGCamilo Gonzalez
Camilo Gonzalez
DVDiana Vargas
Diana Vargas
KCKateir Contreras
Kateir Contreras
PGPaola Garcia
Paola Garcia
PRPatricia Rodriguez
Patricia Rodriguez
CNCarlos Navas
Carlos Navas

22 May 2023 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
KCKateir Contreras-Villamizar
Kateir Contreras-Villamizar
OBOscar Barbosa
Oscar Barbosa
AMAna Cecilia Muñoz
Ana Cecilia Muñoz
JSJuan Sebastián Suárez
Juan Sebastián Suárez
CGCamilo A. González
Camilo A. González
JCJorge Alberto Cortés
Jorge Alberto Cortés
Background: Patients with COVID-19 have a high incidence of acute kidney injury (AKI), which is associated with mortality. The objective of the study was to determine the factors associated with AKI in patients with COVID-19. Methodology: A retrospective cohort was established in two university hospitals in Bogotá, Colombia. Adults hospitalized for more than 48 h from March 6, 2020, to March 31, 2021, with confirmed COVID-19 were included. The main outcome was to determine the factors associated with AKI in patients with COVID-19 and the secondary outcome was estimate the incidence of AKI during the 28 days following hospital admission. Results: A total of 1584 patients were included: 60.4% were men, 738 (46.5%) developed AKI, 23.6% were classified as KDIGO 3, and 11.1% had renal replacement therapy. The risk factors for developing AKI during hospitalization were male sex (OR 2.28, 95% CI 1.73–2.99), age (OR 1.02, 95% CI 1.01–1.03), history of chronic kidney disease (CKD) (OR 3.61, 95% CI 2.03–6.42), High Blood Pressure (HBP) (OR 6.51, 95% CI 2.10–20.2), higher qSOFA score to the admission (OR 1.4, 95% CI 1.14–1.71), the use of vancomycin (OR 1.57, 95% CI 1.05–2.37), piperacillin/tazobactam (OR 1.67, 95% CI 1.2–2.31), and vasopressor support (CI 2.39, 95% CI 1.53–3.74). The gross hospital mortality for AKI was 45.5% versus 11.7% without AKI. Conclusions: This cohort showed that male sex, age, history of HBP and CKD, presentation with elevated qSOFA, in-hospital use of nephrotoxic drugs and the requirement for vasopressor support were the main risk factors for developing AKI in patients hospitalized for COVID-19.

7 February 2017 in Revista Colombiana de Nefrología
Verified
Journal Article
Open access
PDF file
KCKateir Contreras
Kateir Contreras
PGPaola García
Paola García
JPJessica Pinto
Jessica Pinto
PRPatricia Rodriguez
Patricia Rodriguez
CGCamilo González
Camilo González
MBMaría José Vargas Brochero
María José Vargas Brochero
El síndrome hemofagocítico es una entidad causada por hipercitoquinemia y alteraciones del sistema inmune, puede ser hereditario o adquirido y genera alta mortalidad pese al tratamiento. Dentro de las etiologías, las infecciones ocupan un lugar importante, una de ellas la histoplasmosis diseminada, infección oportunista de difícil diagnóstico que afecta a pacientes inmunosuprimidos. Presentamos el caso de una paciente, adulta mayor, trasplantada de riñón, quien presenta síndrome hemofagocítico secundario a histoplasmosis diseminada y, quien presenta respuesta adecuada con el tratamiento instaurado.

1 January 2018 in Cogent Medicine
Verified
Journal Article
Open access
CGCamilo Alberto Gonzalez
Camilo Alberto Gonzalez
JPJessica Liliana Pinto
Jessica Liliana Pinto
VOViviana Orozco
Viviana Orozco
KCKateir Contreras
Kateir Contreras
PGPaola Garcia
Paola Garcia
JEJorge Echeverri
Jorge Echeverri
Introduction: Acute kidney injury (AKI) occurs in more than 50% of critically ill patients, 23% need renal replacement therapy. The aim of our study is to identify early mortality risk factors at the beginning of continuous renal replacement therapy (CRRT) for AKI. Methods: A cohort study was performed in adult patients with AKI who required CRRT in the intensive care unit of a university hospital. We did a bivariate and multivariate analysis for early death, defined as death within 24 h of onset of CRRT. Results: 214 AKI patient required CRRT, The mean age was 61.5 years (± 15.47), 57.73% men. The most frequent cause of AKI was sepsis in 30.9% of cases. A total of 774 CRRT days were conducted with a median of 3 days per patient (1–19). Mean Charlson comorbidity index was 5.22 (± 2.85), APACHE II score 29.65 (± 6.66), total non-renal SOFA had a median of 11 (range 6–18) at the time of starting therapy. The hospital mortality was 68.4% and early mortality was 19.07%. In multivariate analysis for early death: lactate levels (p = 0.007), glucose (p = 0.01) and age (p = 0.02) were independent risk factors with AUC of 0.73. Conclusions: Patients with AKI on CRRT have high mortality. Age, Low glucose and high lactate at onset of CRRT are independent risk factors of early death. We need an external validation.

29 January 2020 in International Journal of Nephrology
Verified
Journal Article
Open access
PDF file
KCKateir Contreras
Kateir Contreras
RBRomar Baquero
Romar Baquero
GBGiancarlo Buitrago
Giancarlo Buitrago
Parathyroidectomy (PTX) is one of the most frequently performed surgeries in chronic kidney disease (CKD) patients. The objective of this study was to determine the intensive care unit (ICU) admission, mortality and hospital readmission rates within the 30-day postoperative period, and the total cost of the care episode and to determine possible prognostic factors in end-stage renal disease (ESRD) adult patients taken to PTX in the Colombian contributory health system.Methods. Retrospective cohort study of ESRD adult patients affiliated to the Colombian contributory health system, on dialysis for at least 3 months, undergoing PTX between January 1, 2012, and November 30, 2016. The clinical outcomes evaluated were rehospitalization at 30 days, hospital stay, and ICU requirement. The costs associated with the hospitalization event in which the PTX was performed from the perspective of the third payer were estimated.Results. The study included 478 patients. The mortality rate was 2.09 per 100 surgeries, the ICU admission rate was 32.64 per 100 surgeries, the 30-day hospital readmission percentage of the postoperative period was 16.74%, and the average length of hospital stay was 5.02 days. The median total costs of care for the entire procedure was USD $ 7,814.27 (p25-p75: 3,922.03–9,372.68), with significant regional differences. The geographical region was shown as a prognostic factor associated with clinical outcomes and the cost of care.Conclusions. There are large regional differences in readmission, ICU admission and mortality rates, and costs of dialysis ESRD patients undergoing PTX belonging to the Colombian contributory regime. The geographic region behaves as an independent predictor of clinical outcomes and costs.